98%
921
2 minutes
20
Objective: Role of texture parameters on the basis of Ga-68 PSMA PET/CT in prostate cancer (Pca) is largely unexplored. Present work done is a preliminary study that aims to evaluate the role of Haralick texture features on the basis of Ga-68 PSMA PET/CT in Pca in which texture features were used to differentiate between normal prostate and Pca tissue.
Methods: The study retrospectively enrolled patients in two groups: group 1 included 30 patients with biopsy-proven adenocarcinoma prostate and median age 64 years (range: 50-82 years) who underwent baseline Ga-68 PSMA PET/CT prior to therapy; group 2 included 24 patients with pathologies other than Pca and median age 53.5 years (range: 18-80 years) who underwent Ga-68 PSMA PET/CT as part of another study in our department. Patients in group 2 did not have any prostate pathology and served as controls for the study. The segmented images of prostate (3-D image) were used to calculate 11 Haralick texture features in MATLAB. SUVmax was also evaluated. All parameters were compared among the two groups using appropriate statistical analysis and P value <0.05 was considered significant.
Results: All 11 Haralick texture features, as well as SUVmax, were significantly different among Pca and controls (P < 0.05). Among the texture features, contrast was most significant (P value of Mann-Whitney U <0.001) in differentiating Pca from normal prostate with AUROC curve of 82.9% with sensitivity and specificity 83.30% and 73.30%, respectively at cut-off 0.640. SUVmax was also significant with AUROC curve 94.0% and sensitivity and specificity 62.5% and 90%, respectively at cut-off 5.7. A significant negative correlation of SUVmax was observed with contrast.
Conclusion: Haralick texture features have a significant role in differentiating Pca and normal prostate.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MNM.0000000000001469 | DOI Listing |
Cureus
June 2025
Urology, Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai, IND.
Xanthogranulomatous prostatitis (XGP) is a rare chronic inflammatory condition of the prostate that can clinically and radiologically mimic prostate cancer (PCa). We present a case of XGP in an elderly male with markedly elevated prostate-specific antigen (PSA) levels and imaging findings suggestive of locally advanced PCa. A 66-year-old male with a two-month history of intermittent fever was incidentally found to have two vesical calculi (13 mm and 9 mm) and grade 3 prostatomegaly (57 cc) with a large median lobe.
View Article and Find Full Text PDFClin Nucl Med
July 2025
Department of Nuclear Medicine, SBU Trabzon Kanuni Training and Research Hospital, Ortahisar, Trabzon, Turkey.
Prostate cancer commonly metastasizes to the skeleton, with multiple bones typically affected. Solitary metastasis in the appendicular skeleton, particularly in the scapula, is exceedingly rare. We present the case of a 75-year-old man with prostate adenocarcinoma, who initially presented with scapular bone metastasis detected using Ga-68 PSMA PET/CT.
View Article and Find Full Text PDFRadiat Prot Dosimetry
June 2025
Faculty of Medicine, Constantine University, Constantine, 25017, Algeria.
Background: The combination of positron emission tomography (PET) and computed tomography (CT) scanning has significantly transformed the field of nuclear medicine.
Purpose: This study aims to establish local diagnostic reference levels (LDRLs) for adult positron emission tomography/computed tomography (PET/CT) scans utilizing three radiotracers:18F-fluorodeoxyglucose (18F-FDG), 68Gallium-prostate-specific-membrane-antigen (68Ga-PSMA), and 68Gallium-etraazacyclododecane-tetraacetic-acid-octreotide (68Ga-DOTATATE).
Methods: Demographic data, radiation dose information, scanner PET/CT system specifications, and acquisition protocols were collected from the Department of Nuclear Medicine at Penang Hospital in Malaysia.
Cureus
February 2025
Theranostics, BAMF Health, Grand Rapids, USA.
Nonagenarians with metastatic castration-resistant prostate cancer (mCRPC) are often underrepresented in prostate cancer research due to their limited numbers among treated populations. For this group, traditional chemotherapy carries significant side effects that can severely impact quality of life. Targeted therapy designed to selectively bind to prostate cancer cells expressing the prostate-specific membrane antigen (PSMA) presents a promising alternative, particularly for those with widespread metastatic disease and contraindications to chemotherapy.
View Article and Find Full Text PDFIndian J Nucl Med
January 2025
Department of Nuclear Medicine, Apollo Main Hospital, Chennai, Tamil Nadu, India.
Certain abdominal and pelvic malignancies present with sensory, motor or autonomic symptoms suggestive of nerve root involvement. Perineural spread of tumor is an emerging explanation of such presentations. This could be seen in carcinoma prostate.
View Article and Find Full Text PDF